HPSE ELISA试剂盒

Zhao, Liu, Ten, Zhang, Yuan, Yu, An: "Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage." in: Renal failure, Vol. 39, Issue 1, pp. 698-701, (2018) (PubMed).

Liao, Wang, Hu, Liu, Shen, Zhang, Yu, Fan, Zhou: "PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection." in: Tumour biology, Vol. 37, Issue 3, pp. 2987-98, (2016) (PubMed).

Hu, Atik, Yu, Li, Zhang, Li, Cai, Yu, Chen, Li, Yuan: "Serum heparanase concentration and heparanase activity in patients with retinal vein occlusion." in: Acta ophthalmologica, Vol. 95, Issue 1, pp. e62-e66, (2016) (PubMed).

Qing, Zhang, Chen, Li, Mao, Chen: "High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression." in: Journal of cellular and molecular medicine, Vol. 19, Issue 6, pp. 1366-74, (2015) (PubMed).

Hu, Zhang, Jin, Zhu, Xu, Wu, Wang, Chen, Webster, Chen, Yu, Wang: "Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis." in: Stem cells (Dayton, Ohio), Vol. 33, Issue 6, pp. 1850-62, (2015) (PubMed).

Chen, Zhang, Sun, Hu, Lu, Ma: "Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase." in: International journal of clinical and experimental pathology, Vol. 8, Issue 5, pp. 4903-12, (2015) (PubMed).

Zhang, Ngo, Wetzel, Marchetti: "Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer." in: Neoplasia (New York, N.Y.), Vol. 17, Issue 1, pp. 101-13, (2015) (PubMed).

Zhang, Qing, Wang, Xu, Zhi, Park, Zhang, Chen: "Syndecan-1 and Heparanase: Potential Markers for Activity Evaluation and Differential Diagnosis of Crohn's Disease." in: Inflammatory bowel diseases, Vol. 19, Issue 5, pp. 1025-1033, (2013) (PubMed).

Hammond, Brandt, Dredge: "PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model." in: PLoS ONE, Vol. 7, Issue 12, pp. e52175, (2013) (PubMed).